EXPD vs HAE · P/E 26, rev $10.60B vs P/E 35, rev $1.36B
Expeditors International of Washington, Inc. (EXPD) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the EXPD and HAE stock pages for the full models.
Not investment advice.